Posted by Surbhi on August 04 2026 at 04:14 PM
public
Burosumab for X-linked hypophosphatemia — the anti-FGF23 monoclonal antibody subcutaneous injection for phosphate-wasting rickets and osteomalacia representing the fastest-growing targeted therap...
The global E-beam cross-linked marine cables market is undergoing a significant technological shift as offshore environments become more extreme and energy demands more complex. Moving away from ...
